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ABSTRACT 
EXERCISE-INDUCED TELOMERASE GENE EXPRESSION IS DEPENDENT 
ON AGE AND GENDER 
 
TRAVIS CLUCKEY 
 
The ability to repair cellular damage is reduced with aging, resulting in 
increased cellular senescence. Telomeres, the protective caps of the 
chromosome, shorten as cells divide but the rate of telomere attrition is regulated 
by two proteins: telomerase and shelterin. An increase in telomerase activity 
could slow down the rate of telomere shortening, while shelterin prevents 
telomere elongation by blocking telomerase. Acute exercise stimulates 
telomerase in young men, as measured by increased expression of telomerase 
reverse transcriptase (hTERT). The aim of the present study was to investigate 
age-related differences in telomerase and shelterin response to exercise. We 
hypothesized that acute exercise would stimulate an increase in telomerase 
activity without an increase in activity of shelterin in both young and older 
individuals and that the hTERT response would be attenuated with aging. Young 
(22 ±2y, n=11) and older (60 ±2y, n=8) men and women performed a 30-minute 
high intensity interval cycling exercise and blood was collected before and at 30, 
60, and 90 minutes after exercise. Gene expression of hTERT and TRF2 
(telomere repeat binding factor 2, a shelterin protein) were measured in 
peripheral blood mononuclear cells (PBMCs) as markers of telomerase and 
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shelterin activity, respectively. Additionally, gene expression of interleukin-6 (IL-
6) was measured as a positive control of the exercise stimulus. The trial induced 
a significant hTERT response in the cohort as a whole (p<0.05) with a greater 
increase in the young as compared to the older group (time-by-age group 
interaction p<0.05). As expected TRF2 did not change in response to the trial, 
however older individuals had significantly higher TRF2 response at +60 min 
(p<0.05).  There was a significant time-by-age group interaction for IL-6 gene 
expression (p=0.048). These data support our hypothesis that telomerase gene 
expression attenuates with age in response to high intensity exercise. 
Unexpectedly, there was a gender difference where men had significantly greater 
hTERT (p<0.05) and TRF2 (p<0.05) responses compared to women, regardless 
of age. The role of gender was a novel finding and should be explored in future 
research.  
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PREFACE 
This thesis is written in journal format according to Northern Arizona University 
thesis guidelines and is divided into chapters with the manuscript being a single 
chapter. The manuscript is written according to the submission guidelines of the Journal 
of Experimental Biology. 
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CHAPTER 1: BACKGROUND 
The aging process comes with natural degradation from cellular division that 
causes telomeres, the protective cap of the chromosome, to shorten. Telomere length 
may be a good indicator of biological age because the rate of degradation is 
accelerated by chronic diseases and psychological stress. Telomerase, a reverse 
transcriptase enzyme, acts as an endogenous defense mechanism by reducing 
telomere attrition. The protective enzyme is only found in highly proliferative cell lines 
such as peripheral blood mononuclear cells (PBMCs), satellite cells in muscle, and 
germ line cells. Telomerase responds dynamically to both acute and long-term stimuli 
including meditation, exercise and stress. What is still unclear is whether telomerase 
activity changes with aging resulting in lower protective capacity. In the present work we 
used high intensity interval cycling exercise to stimulate telomerase activity and 
compared the responses of young and older men and women. We hypothesized that 
exercise stimulates telomerase gene expression in adults; however older individuals 
have a reduced response.   
 
Aging and the Future 
 The average American lifespan is 79 years (Murphy et al., 2013). Although 
lifespan has increased as a result of modern medicine, most Americans spend their last 
two decades of life with an age-related disease (Fries, 1996). The number of Americans 
over the age of 65 will increase to 70 million by 2030, which will be 22% of the overall 
population (Sui et al., 2007). Currently, 80% of older adults will live with at least one 
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chronic age-related disease and 50% of those will live with at least two chronic age-
related diseases (Oeppen and Vaupel, 2002). Today, cardiovascular disease, stroke, 
cancer and type-2 diabetes (T2D) account for 700 billion dollars in direct and indirect 
health care costs every year and these costs are projected to rise as “baby boomers” 
reach the age of 65y  (Eyre et al., 2004; Nelson et al., 2007; Woolf  S MD, 2009).  
Like infectious diseases, many chronic age-related diseases can be prevented or 
delayed, which would greatly reduce health care costs. The onset of age-related 
diseases are postponed by maintaining a healthy diet, exercising regularly, and 
abstaining from tobacco use, which translates to a 80% reduction of cardiovascular 
disease, stroke, and type-2 diabetes (Gremeaux et al., 2012). Presuming all disease 
expenses are evenly distributed, an 80% reduction in risk factors would save 560 billion 
dollars a year. On an individual scale, adults compress the morbidity to mortality ratio 
which is the ratio of living healthy to living with an age-related disease. Adults age 
successfully when they compress the morbidity to mortality ratio.  
Compression	of	Morbidity
55	y	 79	y	
79	y	67	y	
0	y	
0 y	
Figure 1: Visual representation of compressing the morbidity to mortality ratio 
The horizontal bars represent an average lifespan, which is divided into healthspan (blue) and 
morbidity (red). Unsuccessful aging (Jaskelioff et al.) has an early onset of morbidity that lasts 
roughly the last 2 decades of life. While, the goal of successful aging is to increase health span 
and delay morbidity as long as possible (bottom). This figure is adapted from (Fries, 1996). 	
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Telomere Biology  
Telomeres are a unique series of tandem repeats (TTAGGG) for single stranded 
(ss) and double stranded (ds) DNA that prevents chromosomal end-to-end fusion 
(Harley et al., 1990; Zhu et al., 2011). The protective chromosomal cap is conserved 
across the Eukaryota domain with slight modifications in length (Blackburn, 2005). The 
non-coding tandem repeats buffer functional DNA from chromosomal degradation, 
which would trigger cellular senescence. A dsDNA break signal protects tissue by killing 
dysfunctional cells before they have a chance to mutate.  
The majority of the telomere is dsDNA, while the remaining portion is ssDNA 
(Blackburn, 2005; Cesare et al., 2013; Sfeir et al., 2005; Smogorzenska, 1999)(Figure 
2). Shelterin, a complex of 6 proteins, creates and maintains a pseudoknot by binding 
double stranded and single stranded telomeric DNA (Blackburn and Collins, 2011; 
Gilson and Geli, 2007; Stewart et al., 2012; Wolf et al., 2011) and regulates telomerase 
recruitment (de Lange, 2004). The pseudoknot is two interconnected loops called the T 
and D loop (de Lange, 2009). Shelterin binds to the telomere that makes the 
pseudoknot and prevents the structure from unraveling (Baumann and Price, 2010).  
The dual loop structure is formed during telomere replication; however, current research 
only theorizes pseudoknot formation based on model organisms (Blackburn and Collins, 
2011; Gilson and Geli, 2007). Figure 2 illustrates how the ssDNA at the distal end of the 
telomere intersects into the T loop and forms the D loop (Stewart et al., 2012). If 
shelterin is unable to bind to telomeric DNA, the cell signals a dsDNA break and triggers 
DNA repair (Stewart et al., 2012). The repair process compounds telomeric attrition, 
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which reduces its protective capacity and increases the rate of aging. Although the 
pseudoknot prevents apoptosis it creates an obstacle for chromosomal replication.  
 
 
 
 
Figure 2: T-loop and D-loop structure 
The T loop is a protective structure that prevents the chromosome from unraveling and the cell from 
detecting dsDNA breaks. The D-loop is depicted with the 3’ overhang binding to the C-rich strand. 
Shelterin proteins incrementally bind to the telomere in order to protect it from DNA repair and maintain 
the pseudoknot structure [23]. All the proteins surrounding the telomere make up shelterin. This figure is 
taken from (Neumann and Reddel, 2002).  
 
 
Telomere replication has been examined in budding and fission yeasts and in 
human fibroblasts (Blackburn, 2005; Gilson and Geli, 2007). However, the exact in vivo 
mechanisms in humans are yet to be elucidated. Current research suggests two 
possible mechanisms for telomere replication (Gilson and Geli, 2007). The first 
proposes that a DNA helicase enzyme unwinds dsDNA and moves toward the distal 
end of the chromosome. When DNA helicase approaches the pseudoknot, shelterin 
prevents DNA from unwinding and results in supercoiling (Gilson and Geli, 2007). The 
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replication fork pauses and shelterin releases from the DNA. Topoisomerases, then 
unwind supercoiled DNA so the replication fork can continue (Gilson and Geli, 2007). 
The second theory is similar, however, it proposes that  a “chicken foot” is formed rather 
than a supercoil (see figure 3) (Gilson and Geli, 2007). Both theories explain telomere 
replication but do not describe telomere attrition with every division.  
	
Figure 3: Possible terminal telomere structures during replication 
Visual representations of the Chicken foot and supercoiling caused by the T loop and the replication fork 
pausing. The T and D loops of the telomere prevent free rotation at the base of the chromosome, which 
results in supercoiling. This causes the fork to pause and topoisomerases unwind supercoiled DNA. 
Shelterin unbinds from the telomeric DNA and allows the fork to continue replication. Once replication 
continues, the T loop is in an open confirmation and allows telomerase to add telomere segments. The left 
depicts the Chicken foot formation while the right shows how supercoiling is unwound by topoisomerase. 
This figure is taken from Gilson and Geli, 2007.  
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Telomeres protect chromosomal ends from fusing, but they are temporary 
structures that attenuate with age (Werner et al., 2009). Telomeres shorten due to the 
“end replication problem”, when Okazaki fragments from the lagging strand are unable 
to fully replicate the end of the telomere before the 5’ end is fully replicated (Gilson and 
Geli, 2007). This creates a natural 3’ overhang on the lagging strand, while the leading 
strand requires enzymatic modifications to create a 3’ overhang (see figure 4) (Gilson 
and Geli, 2007; Stewart et al., 2012). However, these ideas are based on limited 
observations of yeasts and human fibroblasts.  
 
Telomere and Aging 
Telomeres shorten with every mitotic division due to the end-replication problem 
and the length can be measured to show biological age (Blackburn, 2005; Epel et al., 
2004; Epel et al., 2010; Epel et al., 2006; Epel et al., 2009b; Wolkowitz et al., 2011). 
Telomere length is tightly associated with age in healthy adults, and provides a long-
term history on the health of the individual (LaRocca et al., 2010). Telomeres in satellite 
Figure 4: Leading and lagging strand of DNA after replication  
The leading strand in telomere replication is fully replicated and undergoes enzymatic modifications 
to create a 3’ overhang necessary for D-loop formation. While the lagging strand naturally forms a 3’ 
overhang due to Okazaki fragments. This figure is adopted from Gilson and Geli, 2007].  
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cells, PBMCs, and germ line cells will shorten at the same rate, which suggests their 
maintenance mechanism, telomerase, works at a similar rate (Daniali et al., 2013). 
Therefore, it is appropriate to measure telomerase activity in PBMCs in order to non-
invasively assess telomerase activity in satellite cells, which broadens telomerase 
research in the clinical setting.    
 Telomeres will continue to shorten until reaching the Hayflick point, a critical 
length that triggers a dsDNA break and arrests cell replication. Senescent cells 
accumulate and lead to an older phenotype, making the tissue less functional and 
eventually leading to morbidity. This increases endogenous reactive oxygen species 
and inflammation, which further compounds telomere loss (Franco et al., 2005). 
Individuals with cardiovascular disease, type-2 diabetes, hypertension, atherosclerosis, 
Alzheimer’s disease, Parkinson’s disease and heart failure all have shorter telomeres 
than age-matched healthy adults and these diseases are all associated with increased 
inflammation and oxidative stress (Zhu et al.). Telomere loss is not solely related to 
individual cells but rather an indicator of overall health.   
Telomere length in physically fit older adults is significantly longer than their 
sedentary peers and can even be as long as seen in young adults (LaRocca et al., 
2010). Recent pilot data shows a positive relationship between VO2max and telomere 
length in skeletal muscle, which was largely supported by data from older adults 
(LaRocca et al.). Although the older adults had more cellular turnover than the younger 
adults, there was no significant difference in telomere length between exercisers 
regardless of age (LaRocca et al.). Among older adults, endurance-trained masters 
athletes had significantly longer telomeres than moderate exercisers (Osthus et al.). 
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Taken together, these data suggest that long-term endurance training stimulates a 
telomere protective mechanism that slows telomere attrition.  
 Telomere length is inherited from both parents (Costa Dde et al., 2015; De Meyer 
and Eisenberg, 2015; Ferlin et al., 2013; Hjelmborg et al., 2015) and women have 
significantly longer telomeres than men at birth (Gardner et al., 2013). However, their 
telomeres degrade at a faster rate than men which results in similar telomere lengths 
near age-related death (Needham et al., 2014). It is unclear why women have longer 
telomeres and unknown if there are gender based differences in telomerase activity.   
 
Telomerase Biology 
Telomerase is found in all embryonic cells, but is only detectable in highly 
proliferative cells after birth like (PBMCs), satellite cells, and germ line cells (Daniali et 
al., 2013). Biological systems have a homeostatic balance and telomere length is no 
exception. While mitotic divisions and environmental factors reduce telomere length, 
telomerase functionally lengthens the telomere. Telomerase is a reverse transcriptase 
ribonucleoprotein that adds nucleotides to terminal ends of DNA (Blackburn and Collins, 
2011; Bodnar, 1998; Collins, 2006; Tucey and Lundblad, 2014). The enzyme is 
composed of a functional protein, hTERT, and an mRNA template, TERC (Blackburn, 
2005; Blackburn and Collins, 2011; Chilton et al., 2014; Collins, 2006; Daubenmier et 
al., 2012; Jaskelioff et al., 2011; Oh et al., 2001; Venteicher et al., 2009; Zhu et al., 
2012). hTERT transcribes ssRNA, from TERC, into telomeric ssDNA, which lengthens 
the telomere (Blackburn and Collins, 2011). Telomerase is associated with the telomere 
in between the G2/M phases of the cell division inside of a vesicle called the Cajal body 
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(Cristofari et al.). Telomerase binds to the telomere shortly after DNA replication ends 
and adds roughly 50 nucleotides. Overproducing hTERT allows cells to continuously 
add more nucleotides. However, left unchecked it can lead to unregulated cell 
proliferation and cancer. 
Telomerase concentrations and activity change dynamically in response to acute 
psychological and physical stress (Chilton et al., 2014; Daubenmier et al., 2012).  A 
psychological stressor increases telomerase activity continuing for 90 minutes and is 
associated with increased cortisol (Epel et al.). Interestingly, the stressed group had a 
lower telomerase response than age and gender matched controls (epel). Meditation 
increases telomerase activity as well, which suggests mindfulness directly influences 
aging. Although telomerase activity is not a biomarker of age, it does act as an indicator 
of acute biological health. Therefore, we chose to measure the limiting factor of 
telomerase activity, hTERT, as a representative for telomerase activity.  
 
Telomerase and Aging and Interventions  
 Most existing clinical studies have examined telomerase activity in relation to 
stress, cancer, or strictly in vitro. Only one study to date has investigated changes in 
telomerase activity in response to acute exercise and only included young men (Chilton 
et al., 2014). The subjects ran for 30 minutes at 80% VO2 peak, and hTERT gene 
expression in PBMCs increased from pre- to 60 minutes post exercise (Chilton et al., 
2014). These data indicate that acute exercise stimulates telomerase activity as shown 
by an increase of hTERT. The overall effect of exercise is to protect telomeres by 
increasing telomerase activity and reducing telomeric attrition due to oxidative stress. It 
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follows that regular exercise stimulus could naturally stimulate hTERT and perhaps 
plays a role in successful aging. Although results were significant, the study was limited 
by a lack of gender diversity.   
Telomerase activity increased in response to a 4-month qigong intervention. 
Qigong is a Chinese exercise with gentle movements that focus the body, mind and 
spirit (Ho et al., 2012). Since qigong is a low-intensity activity, it begs the question of 
whether exercise-induced increases in telomerase activity is affected by intensity or 
dose. Alternatively, it is plausible that the effects of qigong on increased telomerase 
activity are primarily through the mental aspects, similar to meditation. In support of this 
possibility, individuals who participated in a 3-month meditation retreat, had significantly 
higher telomerase activity than wait-listed controls (Jacobs et al., 2011). A subjective 
assessment of mental health was given to all participants demonstrating that better 
mental health correlated with higher telomerase activity (Jacobs et al., 2011). Dementia 
caregivers were asked to either meditate or listen to relaxing music for 12 minutes daily 
for 8-weeks (Lavretsky et al., 2013). The meditation group increased telomerase activity 
by 43% after the intervention, versus the 3.7% increase seen in the relaxation group 
(Lavretsky et al., 2013). These data demonstrate that highly stressed adults can 
improve telomerase activity through meditation, and that meditation has a specific 
trigger that can increase telomerase activity. However, this was a pilot study with a 
small sample size, narrow demographic, and a subjective intervention. Nevertheless, 
these data are intriguing but larger studies are needed to give stronger evidence.  
Additionally, telomerase activity has been shown to change in response to a 4-
month Mindfulness-Based Eating Awareness Training and Mindfulness-Based Stress 
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Reduction intervention. At baseline, adults with self-reported psychological distress had 
less telomerase activity and shorter telomeres compared to non-stressed adults. 
Despite not having statistical significance there were correlations between telomerase 
activity and improvements in dietary restraint (Daubenmier et al., 2012). These data 
suggest that telomerase activity can be altered by both psychological and metabolic 
factors. However, the data are limited by the assumption that subjects fully participated 
in the study. There are more pilot data supporting alterations in telomerase activity 
based on dietary changes. However, further research is needed, particularly strict 
dietary interventions to determine whether it can alter telomerase activity.   
To the best of our knowledge only three prior studies describe changes in 
telomerase activity in relation to diet. Telomerase activity was not altered when middle-
aged and older adults were given either a low or high-dose of an omega-3 supplement 
or placebo for 4-months (Kiecolt-Glaser et al., 2013). The intervention significantly 
lowered F2-isoprostanes (indicating lower oxidative stress), decreased n-6:n-3 PUFA 
balance, and increased telomere length (Kiecolt-Glaser et al., 2013).  While there were 
no significant difference in telomere length and telomerase activity between the groups, 
there was a negative correlation between telomere length and n-6:n-3 PUFA balance. 
The negative relationship between telomere length and n-6:n-3 PUFA balance suggests 
telomeres are being protected during a low n-6:n-3 PUFA balance. In addition, these 
data support a crucial link between oxidative stress and telomerase activity. The second 
dietary study saw no change in telomerase activity after a vitamin D supplementation in 
middle-aged African American males (Zhu et al., 2012).  Finally a recent follow-up study 
was conducted on prostate cancer survivors who had undergone a long-term 
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intervention shortly after surgery and were reassessed 5 years after the intervention 
(Ornish et al., 2013). Telomerase activity increased amongst the group, but telomere 
length remained the same (Ornish et al., 2013). No change in telomere length means 
their biological age had not significantly changed over 5 years and they had reduced 
their rate of aging. Since telomerase is primarily recruited to the shortest telomere, the 
data support the shortest telomeres were maintained. Although healthy cancer survivors 
have healthy telomeres and telomerase activity, the study had several confounding 
factors such as diet, exercise, and mental health. However, it represents a more 
realistic version of a long-term intervention for patients. The data support that a healthy 
diet can alter telomerase activity; however, further research is required to determine 
how diet directly impacts telomerase activity.  
Recent and perhaps the most promising TERT interventional research focuses 
on gene therapy in a mouse model (Bernardes de Jesus et al., 2012). Previous studies 
show benefits in health biomarkers through exercise interventions and increases in 
telomerase activity through meditation but neither are able to replicate these data 
(Bernardes de Jesus et al., 2012). Young and middle-aged cancer-resistant mice were 
injected with a retrovirus carrying TERT, which then overexpressed TERT. As a result 
the mice experienced a change toward a younger phenotype  (Bernardes de Jesus et 
al., 2012). Insulin sensitivity, osteoporosis, neuromuscular coordination, and several 
aging biomarkers were significantly improved with the TERT intervention. These mice 
did not experience any p53 mutations, which indicates controlled cellular replication, 
and was expected (Bernardes de Jesus et al., 2012). TERT mice lived a median 24% 
longer lifespan compared to the age-matched controls. TERT amplification through retro 
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viral infection can be a feasible intervention to reduce the rate of aging and increase 
longevity, but further research is needed to determine if the increased lifespan and lack 
of mutation rate can be replicated.  
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CHAPTER 2: EXERCISE-INDUCED TELOMERASE EXPRESSION IS DEPENDENT  
ON AGE AND GENDER 
 
 
 
Travis G.  Cluckey1, Nathan C. Nieto1, Bridger M. Rodoni1, and Tinna Traustadóttir1* 
1Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona. 
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Abstract 
 
The ability to repair cellular damage is reduced with aging, resulting in increased cellular 
senescence. Telomeres, the protective caps on the chromosomes, shorten as cells 
divide. Telomere attrition is regulated by two proteins: telomerase and shelterin. The 
aim of the present study was to investigate age-related differences in telomerase and 
shelterin responses to acute exercise. We hypothesized that acute exercise would 
stimulate an increased activity of telomerase (measured by telomerase reverse 
transcriptase, hTERT) without an increase in activity of shelterin (measured by telomeric 
repeat binding factor 2, TRF2) in both young and older individuals and that hTERT 
response would be attenuated in older individuals. Young (22 ±2y, n=11) and older (60 
±2y, n=8) men and women performed a 30-minute high intensity interval cycling. Blood 
was collected before exercise and at 30, 60, and 90-min post exercise and gene 
expression of hTERT and TRF2 were measured in peripheral blood mononuclear cells. 
Interleukin-6 mRNA was measured as a positive control of the exercise stimulus. The 
trial induced a significant hTERT response in the cohort as a whole (p<0.05) with 
greater increases in the young as compared to the older group (time-by-group 
interaction p<0.05). As expected, TRF2 did not change in response to the trial, however 
older individuals had a higher TRF2 response at 60 min (p<0.05).  There was a time-by-
group interaction for IL-6 gene expression (p=0.048). There was an unexpected gender 
difference, regardless of age, where men had significantly greater hTERT (p<0.05), and 
TRF2 (p<0.05) responses to the acute exercise as compared to women. These data 
support the hypothesis that aging is associated with attenuated telomerase activation in 
response to high intensity exercise; however, this was only evident in men. 
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Introduction.  
Telomeres, the protective cap at the terminal end of linear chromosomes, shorten with 
every cellular replication and, as a result, telomere length shortens with age (Aviv, 2006; 
Cherkas et al., 2008; Damjanovic et al., 2007; Daniali et al., 2013; de Lange, 2009; Epel 
et al., 2009a; Gilson and Geli, 2007; Ludlow et al., 2008; Osthus et al., 2012; Sfeir et al., 
2005).  However, physical activity may protect against age-related telomere shortening 
as endurance-trained older individuals have similar telomere length as young adults 
(LaRocca et al., 2010). It has not been well elucidated how exercise can modify 
telomere biology but it may be, through increasing the activity and/or abundance of 
telomerase . Telomerase, a reverse transcriptase enzyme, reduces telomere attrition by 
adding nucleotides to the end of the chromosome shortly after DNA replication (Axelrad 
et al., 2013; Blackburn and Collins, 2011; Chilton et al., 2014; Collins, 2006; Cristofari et 
al., 2007; Gilson and Geli, 2007; Herrera et al., 1999; Hwang et al., 2014; Ludlow et al., 
2008; Schmidt et al., 2014; Venteicher et al., 2009).  
The enzyme is composed of a functional protein, hTERT, and an mRNA template, 
TERC. Because hTERT is the limiting factor in functional telomerase activity, it can be 
used as a measure of telomerase function (Chilton et al.). Shelterin is a complex of six 
proteins, including TRF2, which acts as a negative regulator of telomerase activity by 
controlling telomerase binding to the telomere (de Lange). Lack of telomerase has been 
shown to accelerate aging in a cell model (Bernardes de Jesus et al.) while acute 
exercise has been shown to stimulate telomerase activity, as measured by an increased 
gene expression of hTERT in young men (Chilton et al., 2014). What is not known is 
whether the same response would be observed in older individuals. We have previously 
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demonstrated that acute exercise induces a protective effect to a subsequent oxidative 
stress challenge in young but not older adults (Nordin et al., 2014). Additionally, acute 
exercise increased antioxidant cell signaling in young men but this response was 
impaired in older men (Newell et al., 2016). These data suggest that aging is associated 
with reduced ability to stimulate protective pathways regulated by cell signaling. We 
therefore hypothesized that exercise-induced telomerase activation would be attenuated 
with age.  
Telomerase activity was measured by changes in hTERT mRNA and shelterin was 
measured by TRF2 mRNA in response to a 30-minute bout of acute exercise, measured 
in PBMCs at baseline and 30, 60, and 90-minutes post-exercise. We predicted that 
hTERT would increase in response to acute exercise while TRF2 would not change. In 
addition, IL-6 mRNA was measured as a positive control to verify the success of the 
exercise stimulus.  While earlier studies only included men, the present study included 
both men and women for gender diversity. We used high-intensity interval cycling 
protocol as the acute exercise stimulus because data from our laboratory comparing 
constant workload to a high-intensity interval protocol demonstrated a greater 
antioxidant enzyme response from the latter (Newell et al.). Evidence of gender effects 
in telomerase activity are lacking; therefore, our secondary aim was to explore potential 
gender difference in the exercise-induced telomerase response. 
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Methods.  
Participants 
Twelve young (18-25y) and 8 older (55-75) recreationally active men and women were 
recruited from the community. Recreationally active was defined as having a VO2 max 
less than 70th percentile based on age and gender. Study participants were generally 
healthy, non-smokers, who were not taking antioxidant supplements in excess of a 
multivitamin, or any non-steroidal anti-inflammatory (NSAIDS) drugs for two weeks prior 
to their study visit. Participants were not overly obese (BMI≤33.0kg/m2) and were free 
from cardiovascular, pulmonary, and metabolic diseases. In addition, regular meditation 
was an exclusion criterion because existing studies have identified meditation as a 
telomerase activity modifier (Jacobs et al., 2011; Lavretsky et al., 2013). Any individual 
who had experienced a myocardial infarction within the last six months or had a history 
of angina was excluded. In addition, participants who exhibited clinically relevant 
arrhythmia at rest or during the maximal stress test were excluded. All participants 
signed a written informed consent approved by the Northern Arizona University 
Institutional Review Board (Appendix 1). 
Study Design  
The study employed a cross-sectional design (see Figure 1).  Prior to the study trial, the 
participants went through a screening visit and a test of maximal oxygen consumption 
(VO2 max).  The acute exercise trial was separated from the VO2 max test by at least 
two days to control for any confounding effects of exercise. Regardless of age or 
gender, all participants performed a high intensity interval protocol on a stationary cycle 
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for 30-minutes at an intensity relative to their maximum capacity as described below. 
Blood samples were taken before, 30, 60, and 90 minutes after exercise, see figure 1. 
 
Screening Visit 
Prior to any exercise testing the participants completed a health history questionnaire. 
Height, weight, waist circumference, and resting blood pressure were measured and a 
12-lead supine resting EKG was obtained for screening any abnormalities that would 
exclude the participant from the study.  
 
Maximal Oxygen Consumption (VO2 max) Test  
VO2max was measured with a graded exercise test performed on a cycle ergometer as 
previously described (Traustadottir et al., 2012). The starting workload was selected 
based on the predicted maximal workload for each individual, and was increased every 
minute until volitional exhaustion. Participants were instructed to maintain a pedaling 
rate of 60-70 rpm throughout the test.  Oxygen consumption was measured by indirect 
calorimetry using a metabolic measurement cart (Vmax29, CareFusion, Yorba Linda, 
CA). Heart function was monitored with continuous 12-lead EKG. VO2max was 
considered achieved if two of the following three criteria were met: (1) a plateau in VO2 
with an increase in workload, a respiratory exchange ratio (RER) ≥ 1.10, and  heart rate 
within 10 beats of age-predicted maximal heart rate (Kohrt et al., 1991). Standard 
contraindications to exercise testing, and termination criteria outlined by ACSM, 
American College of Sports Medicine, were followed at all times.  
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High Intensity Interval Exercise Trial 
Subjects completed 30-minutes of cycling at varied workloads consistent with interval 
training. Breath-by-breath analysis of oxygen consumption was measured throughout 
the trial using indirect calorimetry to ensure target interval intensities were met. 
Participants began with a progressive six-minute warm-up broken into two minute steps 
corresponding to approximately 40-, 60-, and 80% VO2max. The instructions 
participants received to achieve target VO2 utilized the Borg CR10 scale (Borg, 1998). 
Participants were asked to complete the first two minutes at an intensity corresponding 
with a three out of ten, the second two minutes at a five out of ten, and the last two 
minutes at a seven out of ten, while investigators monitored the oxygen consumption to 
ensure the appropriate intensities were achieved. The warm-up period was followed by 
a 3-minute recovery at an intensity corresponding to approximately 60% VO2max. 
Subjects then completed a total of seven high intensity intervals, each comprised of one 
minute of high intensity followed by two minutes of recovery. For the high intensity 
intervals, subjects were instructed to work at the highest absolute intensity they could 
maintain for one full minute. The target intensity of each interval was set at 90% 
VO2max. Subjects who did not achieve the target intensity within the first interval were 
given subsequent instructions to increase the workload for the following intervals. 
Recovery bouts were completed at a self-selected intensity.  
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Peripheral Blood Mononuclear Cell Isolation 
Whole blood was collected with a 21-gauge butterfly needle (Becton Dickinson, Franklin 
Lakes, NJ) from a superficial antecubital vein. Samples were collected into EDTA 
vacutainers to prevent coagulation. Whole blood was diluted 1:1 with phosphate 
buffered saline (PBS) and layered onto Ficoll-Paque PLUS (GE Healthcare, Uppsala, 
Sweden). Samples were spun at 900xg for 30 minutes at room temperature, per 
manufacturer’s directions. Following centrifugation, the lymphocyte rich layer was 
collected and washed twice in PBS with phosphatase inhibitors (Halt Phosphatase 
Cocktail, ThermoFisher, Waltham, Massachusetts) at 400xg for 10 mins at 4°C. PBMCs 
were counted using Countess Automated Cell Counter (Life Technologies, Waltham, 
MA) and aliquots of 2x106 were made and stored with 200 µL of RNAlater at -80°C until 
analyses. 
 
RT-qPCR – Reverse transcriptase quantitative polymerase chain reaction 
PBMC aliquots were lysed using buffers to manufacturer specifications (Qiagen, Hilden, 
Germany) and RNA was extracted.  Sample RNA was quantified (Gen5 ver. 2.09, 
Winooski, VT) and tested for RNA purity prior to cDNA synthesis. Equal amounts of 
sample were reverse transcribed using the iScript RT kit (Bio-Rad, Hercules, CA). A 
20µl reaction of Ssofast SYBR green (Bio-Rad, Hercules, CA), target primers 
(ThermoFischer, Waltham, MA), nuclease free water and sample cDNA were mixed and 
aliquoted into 96-well optical plates. Every gene of interest (primer sequences in table 
1) was analyzed in triplicate using a Bio-Rad thermocycler with CFX Manager software 
(Bio-Rad, Hercules, CA) for 40 cycles (two steps: 95°C for 5 s followed by 55°C for 10 
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s). Each 96-well optical plate held samples at all time points in triplicate for 2 subjects 
and each pair of selected subjects came from different demographics in order to prevent 
bias sample analysis.   
   
Statistical Analyses  
Data analyses were conducted using SPSS (version 23, Chicago, IL). Data are 
presented as means and standard error of the mean. An independent t-test was used to 
analyze differences in subject demographics. Gene expression was calculated by taking 
the mean Ct of samples and using the ∆∆Ct formula as previously described 
(Vandesompele et al., 2002). Fold change was calculated in relation to pre-exercise 
values, by 2-(∆∆Ct), and log change was calculated and used in all statistical analyses. 
Differences in gene expression in response to the acute exercise were analyzed by 2 x 
4 (group-by-time) ANOVA with repeated measures on the second factor. Gender was 
entered as a covariate as significant gender differences emerged for both hTERT and 
TRF2. Where the data did not meet assumptions of sphericity, the Huyhn-Feldt 
correction is reported. All comparisons were considered significant at p<0.05.  
 
Results 
Of the 38 subjects screened for the study, a total of 27 subjects met the inclusion 
criteria and consented to participate. During the course of the study seven subjects had 
to be removed due to continually missing study appointments. The study cohort 
consisted of 12 young (22 ±2y, 5 men, 5 women) and 8 older (60 ±2y, 4 men, 4 women) 
individuals. Examination of the data revealed one outlier; a young man had hTERT and 
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TRF2 values at the 30-minute time point that were >4 SD’s from the mean of the rest of 
the cohort. The data from this individual were excluded from the final analyses. The 
data reported are therefore comprised of 11 younger (5 men, 6 women) and 8 older (4 
men, 4 women) individuals whose characteristics are summarized in table 1. The goal 
intensity of the maximal intervals in the HIIP trial was set at 90% of their VO2 max. The 
actual achieved average intensity was 92%, and did not differ significantly between the 
young and older groups, or between men and women. 
 
Effects of aging on exercise-induced telomerase activity 
The high intensity exercise trial significantly increased hTERT expression (figure 2-A) in 
the cohort as a whole (p<0.05) with a greater increase in the young as compared to the 
older group (time-by-age group interaction p<0.05). The older group had their peak 
response at the 60-minute time point (2.6-fold increase) and returned to baseline by 90-
minutes, whereas the young group had their highest response at the 90-minute time 
point (6.2-fold increase). As expected TRF2 did not change in response to the trial 
(figure 2-B), however there was a significant effect of age (p<0.05) driven by the older 
individuals having a significantly higher TRF2 response at +60 min. There was a 
significant time-by-age interaction in IL-6 gene expression (p=0.048). Similar to the 
hTERT response, older individuals peaked IL-6 expression +60-minutes and then 
returned to baseline while young adults continued to increase at the +90-minutes. 
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Effects of gender on exercise-induced telomerase activity 
There was a significant main effect of gender for the hTERT response to exercise 
(p<0.05) and the interaction between gender and time trended toward statistical 
significance (p=0.054). The hTERT response for men and women by age group is 
shown in figure 3. There was also a significant main effect of gender for TRF2 (p<0.05) 
where women had a lower response compared to men (data not shown). 
 
Discussion  
This study tested the hypothesis that telomerase activation would be attenuated with 
aging in response to acute exercise. The hypothesis was supported by a significant 
time-by-age group interaction for hTERT expression in response to high intensity 
cycling exercise. The pattern of interaction came from the older group increasing 
hTERT expression for 60 minutes after the completion of the exercise bout and then 
returning back to baseline levels at 90 minutes while the young group continued to 
increase hTERT over the 90-minute sampling period.  It is therefore unknown whether 
they had reached their peak response or if it would continue to increase had the 
sampling period been longer. These data are in agreement with Chilton et al. (Chilton et 
al., 2014) who demonstrated an increase in hTERT in young men in response to acute 
exercise. Their last time point was 60 minutes post-exercise and that time point showed 
the highest increase. Based on their data, we had extended the sampling period to 90 
minutes but clearly this must be prolonged further in order to capture the complete 
response in young. Additional support of our hypothesis is demonstrated by the 
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maximal increase in hTERT expression being 2.3-fold greater in young compared to 
older individuals (6.2- versus 2.6-fold increase, respectively). 
 
Older individuals increased hTERT expression at the 60-minute time point, which 
coincided with a peak in TRF2 expression (not observed in young at any time point). 
TRF2 was measured as an indicator of shelterin activity and it negatively regulates 
telomerase activity. Shelterin prevents telomerase from accessing the telomere and 
elongating the single stranded telomeric DNA. Therefore, the increase in TRF2 
expression concomitant with the increase in telomerase expression may indicate that  
the age-related difference was even greater in terms of biological significance. 
Secondly, the unexpected but stark gender differences demonstrate that the age-related 
differences in exercise-induced hTERT expression comes entirely from the response of 
young and older men while the response of young and older women is negligible (see 
figure 3). To our knowledge, this is the first study to include both men and women while 
investigating the exercise-induced response of telomerase activity. However, our study 
was not statistically powered to investigate gender differences within age groups. This 
area clearly warrants further study with greater number of subjects per gender.  
 
Although differences in telomerase activity between genders have not been well 
described, gender differences in telomere length are better understood. Women have 
longer telomeres at birth (Gardner et al., 2013), but their telomeres degrade at a faster 
rate than men (Needham et al., 2014). Perhaps women do not stimulate hTERT after an 
oxidative insult, because their telomeres are well buffered from damage by a greater 
		 26 
number of tandem repeats, while men may produce hTERT to compensate for short 
telomeres that are exposed to oxidative damage. Alternatively, it has been proposed 
that men have shorter telomeres simply because they have the Y chromosome that 
cannot contribute to telomere length whereas both sex chromosomes in women 
contribute to telomere length (Gardner et al., 2013). Estrogen contributes to various 
physiological gender differences, however, it is unlikely to be the explanation for the 
results in the present study because we controlled for subjects who were on estrogen 
replacement therapy and oral contraceptives. In addition, there are existing data 
showing that physiological levels of estradiol do not affect telomerase activity (Benko et 
al., 2012).  
 
The exercise stimulus used in this study was a high-intensity interval cycling protocol 
that we have used in previous studies. It is somewhat surprising that we did not find a 
significant main effect of time in IL-6 expression in response to this high intensity 
exercise protocol. A recent study that used a similar exercise protocol demonstrated a 
significant increase in IL-6 mRNA, however, the post-exercise measure was taken 
immediately after completing the exercise session (Cullen et al., 2016). It is possible 
that our time points did not capture the response which may have occurred prior to 30 
minutes post-exercise and/or after 90 minutes. Admittedly our time points were chosen 
based on data for hTERT. Alternatively, the duration of the exercise session may not 
have been long enough to induce an acute phase inflammatory response and this 
conclusion is supported by a recent systematic review that found that IL-6 gene 
expression does not change significantly in response to acute exercise (Gjevestad et 
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al., 2015). Nevertheless, there were no significant differences in the relative intensity of 
the intervals between age groups or by gender and therefore it is unlikely that the 
observed differences in telomerase activity were due to the exercise stimulus being 
different between groups.  
 
In summary, the present study demonstrated that high intensity interval cycling induced 
an increase in hTERT gene expression in men, which was attenuated with age. In 
addition, the older men had an increase in the negative regulator of telomerase, TRF2, 
at the same time point where their peak response in hTERT occurred. Young and older 
women did not show any significant changes in these markers in response to exercise. 
 
Limitations 
We acknowledge several limitations to our study including a small sample size, 
especially in the older subject group. Another limitation is that the measurement of 
hTERT protein and telomerase activity was not included in the study. These additional 
measures would help further explain in vivo telomere biology and its response to 
oxidative challenges. It would also clarify whether hTERT gene expression accurately 
reflects telomerase activity. Finally, as mentioned earlier, this study was not statistically 
powered to investigate gender differences within age groups.  
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Conclusions and Future Directions 
 
Exercise stimulates hTERT expression and in turn increases telomerase activity in men, 
especially young men. Men increase telomerase activity to reduce their telomere loss 
caused by oxidative damage. Similar to antioxidant capacity, young adults have a 
greater protective ability than older adults, which prolongs aging characteristics. Older 
men produce more negative regulators than young adults as well, which contributes to 
the idea that older men lose their ability to protect telomeres. Aging impairs hTERT 
expression, which reduces the cells longevity and contributes to an aged phenotype.  
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 Target Gene FWD/REV Primer Sequence 
GAPDH FWD GAAGGTGAAGGTCGGAGTC 
GAPDH REV GAAGATGGTGATGGGATTTC 
hTERT FWD TACGGCGACATGGAGAACAAG 
hTERT REV GGGCATAGCTGAGGAAGGTTT 
TRF2  FWD  CCCAAGAACAAGCGCATGAC 
TRF2   REV GGGTTGGTTGAGAACGGTGG 
IL-6 FWD GGTACATCCTCGACGGCATCT 
IL-6 REV GTGCCTCTTTGCTGCTTTCAC 
Table 1: Target gene primer sequences  	
		 31 
 
(BMI) Body mass index; (SBP) Systolic blood pressure; (DBP) Diastolic blood pressure; (HR max) Heart 
rate max in beats per minute; (VO2max) maximal aerobic capacity; (RER) Respiratory exchange ratio; 
(WC) Waist Circumference; (WL) Workload max. *p<0.05 **p<0.01 
 
  
 Description Young (n=11) Older (n=8) p-value 
Age (yrs) 22 ± 2 60 ± 2 <0.001** 
Gender ratio(M/W) 5/6 4/4  
Height (cm) 174 ± 11 176 ± 8 NS 
Weight (kg) 75.6 ± 18.2 79.3 ± 10.5 NS 
WC (cm)  84.4 ± 12.1  96.5 ± 7.4 0.028* 
BMI (kg/m2)   25.0 ± 3.7 25.6 ± 2.2 NS 
SBP (mmHg) 119 ± 7 126 ± 9 NS 
DBP (mmHg) 75 ± 6 83 ± 6 0.009** 
HR max (bpm) 187 ± 7 166 ± 8 <0.001** 
VO2max (mL/kg/min) 38.1 ± 6.3 29.2 ± 6.1 0.006** 
RER max  1.21 ± 0.06 1.26 ± 0.05 NS 
WL max (watts) 217.7 ± 67.3 183.1 ± 61.3 NS 
Average HIIP peak  87% ±5% 97% ± 13% NS 
Table 2: Subject Demographics between young and older adults 
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Figure 1: Study Design 
Generally healthy, non-smoking young (18-25y) and older (55-75y) men and women were recruited for 
this study. Each subject’s demographics, vitals, and self-reported medical history were measured and 
recorded. Subjects completed a maximal oxygen consumption (VO2 max) test on the same day. At 
least 2 days later, participants completed a high intensity interval protocol (HIIP) for 30-minutes, which 
consisted of a 9-minute warm-up followed by 7 intervals with 1 minute at approximately 90% VO2 max 
and 2 minutes at approximately 50 – 60% VO2 max. Blood was taken before exercise with additional 
draws 30, 60 and 90-minutes after exercise.   
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Figure 2: The effect of 
aging on gene expression  
PBMC hTERT gene 
expression responses to 
HIIP in healthy young and 
older adults. Values are 
means ± SEM, n = 19, for 
fold change from Pre 
exercise through 90 minutes 
post. HIIP increased PBMC 
hTERT gene expression 
(main effect of time, p<0.05). 
There was a main effect of 
age (p<0.05) in TRF2 
expression. HIIP increased 
IL-6 expression and had a 
significant time-by-age 
interaction (p<0.05)   
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hTERT expression by age and gender
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Figure 3: The effects of age and gender on hTERT expression 
Values are means ± SEM, n = 19 for fold change from pre to 90 minutes 
post exercise. HIIP increased hTERT gene expression with a significant 
main effect of gender (p<0.05).  
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NAU Human Subject  
Informed Consent  
 
 
Biological Sciences, Building 21, (928) 523-7291 
 
Project Title: 
 
Telomerase Activity: a dynamic measure of age 
 
Dear Subject, 
 
You are being asked to participate in a research project conducted through the Department of 
Biological Sciences at Northern Arizona University by Travis Cluckey, a graduate student, under 
the supervision of Dr. Tinna Traustadóttir (a faculty member in the Department of Biological 
Sciences). The researcher is required to receive your informed consent before you participate in 
this project.  
 
Study personnel will explain to you in detail: (1) the purpose of the project; (2) what you will be 
asked to do and how long your participation will last; (3) how your personal information, if 
collected, will be kept confidential; (4) if you will receive any compensation; (5) the possible 
risks; and (6) potential benefits of participation.  
 
Your participation in this research is voluntary. If you refuse to participate, there are no penalties 
or loss of benefits or services that you are otherwise entitled. If you decide to participate and 
then withdraw or skip a question there are also no penalties or loss of benefits or services. 
Whether or not you choose to participate in this project will have no effect on your relationship 
with NAU now or in the future. 
 
A basic explanation of the project is written below. Please read this explanation and discuss it 
with the Principal Investigator. Feel free to ask questions to help you understand the project. 
 
After any questions you may have are answered and you decide to participate in the research, 
please sign on the last page of this form in the presence of the person who explained the project 
to you. A copy of this form will be given to you to keep. 
  
 
1. PROJECT PURPOSE: 
	
Appendix 1: NAU IRB Informed Consent 
	 47 
 
We are interested in understanding how exercise reduces risk for chronic diseases, specifically 
through lowering oxidative stress. In this project we are trying to learn more about the specific 
pathways that are activated in response to exercise, and whether the response changes with 
aging. All portions of this study will be conducted at Northern Arizona University in the 
Traustadóttir laboratory.  
 
 
2. EXPLANATION OF PROCEDURES: 
 
This study requires you to make 2 visits to the laboratory. The first is a screening visit that also 
may include a maximal exercise test, and the second is an exercise trial. Both are explained 
below. The total time commitment in the lab during the study is approximately 3 hours within a 
2-week period. A summary table outlining details of each visit and associated time commitments 
is provided below for your reference.  
 
It is possible that your participation in the study may be ended if the screening visit results 
reveal that you do not meet the inclusion criteria. For example you may be excluded from the 
study based on data collected from the screening visit, inability to complete exercise protocols, 
or if you have any cardiac abnormalities.  
 
There is also a potential to be excluded from the study at any point if you no longer meet the 
inclusion criteria, if you are unable to complete an exercise trial or, if you have and any other 
abnormalities or contraindications. If you are excluded from the study, all documentation will be 
destroyed immediately, except this informed consent, which will be retained for 3 years following 
completion of the study.  
 
Visit 1: Screening Visit 
You will be asked to come to the Traustadóttir laboratory for a screening visit lasting for 
approximately 1 hour.  After the researches answer any questions you may have regarding the 
study and if you agree to participate by signing this informed consent, we will measure your 
height, weight, resting blood pressure, and waist circumference. You will be asked to fill out a 
questionnaire about your health history, medication and supplement use, and physical activity. 
A resting electrocardiogram (EKG - tracing of the electrical activity of the heart) will be obtained to 
check for indications of heart disease. Your EKG will be evaluated by an exercise physiologist 
or if necessary our physician if necessary to determine if you have any cardiac abnormalities. If 
you’re eligible and would like to continue participation in the study you will be asked to perform 
the maximal exercise test described below.    	
Maximal Exercise Test 
You will be asked to do a maximal exercise test (commonly known as a “stress test”) on a 
stationary bicycle.  While performing this test, you will breathe through a mouthpiece and have 
electrodes attached to your chest so we can monitor your heart. This test can uncover 
unsuspected heart disease. If we detect any abnormalities during the test, we will recommend 
that you see your physician or refer you to a cardiologist. You or the research personnel may 
stop the test early if indicated. The test is a measurement of your cardiovascular capacity. Your 
maximal cardiovascular capacity will be used to determine your constant workload on the 
stationary bike, which is described below.  	
Visit 2: Acute Exercise Trial 	
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This visit will take approximately 2 hours. We ask that you do not exercise or perform overly 
strenuous activity for 48-hours prior to the visit. You will be asked to perform an exercise trial on 
a stationary bicycle, which, consists of 30-minutes of cycling at varying intensities. After a 9 
minute warm-up on the bike, you will complete a high-intensity bout for 60-seconds, followed by 
2-minutes of recovery. You will repeat this for a total of 7 repetitions. The high-intensity bout is 
at the highest intensity you can maintain consistently for one-minute, approximately 90% of your 
maximal capacity. While performing this test, you will breathe through a mouthpiece and have 
electrodes attached to your chest so that we can monitor your heart. You will have access to 
water or Gatorade as needed. You or the research personnel may stop any of these tests early 
if indicated. We will take a blood sample before you begin the exercise trial and additional blood 
samples 30, 60, and 90 minutes after you complete the exercise, for a total of 4 blood draws. 
The total amount of blood taken during three draws will be approximately 1.5 tablespoons or 
1/20th of a standard blood donation.  
 
Summary of visits and Procedures – both visits will occur within a 2-week period  
 
Visit 
# 
Procedure Location Summary of Events Time 
Commitment 
1 Screening 
Visit 
Traustadóttir Lab 
Biology Bldg (#21) 
Room 121 
Measure: height, weight, blood 
pressure, resting EKG 
Collection: health history, informed 
consent  
 
If subject qualifies, then: 
 
Maximal Exercise Test  
 
1 hour 
2 Acute 
Exercise 
Trial 
Traustadóttir Lab 
Biology Bldg (#21) 
Room 121 
Subject will exercise for 30-
minutes on a stationary bike 
alternating between high and low 
intensity intervals 
 
4 Blood draws a pre-exercise, 30, 
60, & 90 after exercise 
 
2 hours 
 
3. CONFIDENTIALITY: 
 
Steps are being taken to protect your information. The principal investigator (Travis Cluckey), 
and other study personnel will have access to confidential study-related records that identify you 
by name. Absolute confidentiality cannot be guaranteed. However, to reduce the risk of breach 
in confidentiality, you will be assigned a study ID upon enrollment. Your name will only be linked 
to your study ID on a single document that will be kept in a locked file cabinet separate from 
other research records. This document will be destroyed immediately upon completion of the 
study in full. This document will not have any titles linking it to the study, and will only contain 
names and study ID’s of all subjects. All records that contain data collected from you will be 
labeled with your study ID and will be kept in a locked cabinet, or in secured documents on 
password-protected computers. All blood samples will be labeled with study ID, and will be 
analyzed in our laboratory. Results from this study may be published in relevant scientific  
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journals or presented at regional, or national meetings and will not contain any identifying 
information.  
 
 
4. COMPENSATION: 
   
There is no compensation for your participation in this study.  
 
 
5. COSTS OF PARTICIPATION  
 
You will be responsible for transportation to Northern Arizona University; however parking 
passes are available free of charge from our lab. Your total time commitment for the study will 
be 3 hours.  
 
 
6. BENEFITS OF PARTICIPATION 
 
You will not receive any medical benefit from participating in this study. However, the results of 
the stress test and EKG will be shared with you.  
 
 
7. RISKS: 
 
Blood Draws: 
The side effects of inserting needles into veins may include mild pain, bleeding, and/or bruising.    
Very rarely, complications such as a blood clot or an infection may occur.  Some subjects may 
feel faint when blood is drawn. To minimize the chance of bruising we will wrap the blood draw 
site with medical wrapping immediately after withdrawal of the needle. In the event of unusual 
bruising or soreness after leaving the lab facility please contact lab personnel for referral, or 
Campus Health Center, 928-523-2131.  
 
Exercise Testing: 
The risks of the exercise testing include shortness of breath, leg fatigue and possible muscle 
soreness. The major risks include abnormal heartbeat, heart attack, and death.  
These complications are rare and exercise testing is generally considered a safe procedure with 
the risks of fatal and nonfatal events in healthy adults is less than 0.8 per 10,000 tests.  You or 
the research personnel may stop the test at any time. The test may be stopped by lab personnel 
if there are any abnormalities as well. Subjects who have evidence of heart disease during the 
screening test will not be allowed to participate in this study.  Emergency equipment and trained 
personnel will be available to deal with unusual situations that may arise. EMS will be contacted 
in the event of an emergency, and trained personnel will offer appropriate care until EMS 
arrives. You will be responsible for any costs associated with emergency medical services that 
are not provided by NAU research personnel 
 
8. RIGHTS IF YOU DECIDE TO TAKE PART IN THIS RESEARCH STUDY: 
 
You have the right to ask questions about any part of the study at any time.  You should 
not sign this form unless you have had a chance to ask questions and have been given 
answers to all of your questions.   
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If you agree to participate in this study, then consent does not waive any of your legal 
rights.  However, no funds have been set aside to compensate you in the event of injury.  
 
 
9. CONSENT: 
 
I have read the above information about “Telomerase Activity: a dynamic measure of age” and 
have been given an opportunity to ask questions. I agree to participate in this project, and I have 
been given a copy of this consent document. I am over 18 years of age.  
 
 
____________________________________________   Date _________________ 
          Signature of Subject 
 
____________________________________________    
        Printed Name of Subject 
 
 
____________________________________________   Date _________________ 
    Signature of Research Representative 
 
____________________________________________    
 Printed Name of Research Representative 
 
 
The dated approval stamp in the header of this consent form indicates that this project has been 
reviewed and approved by the Northern Arizona University Institutional Review Board (IRB) for 
the Protection of Human Subjects in Research. Contact the Human Research Protections Office 
at 928-523-9551 if you have any questions about: (1) the conduct of the project, or (2) your 
rights as a research subject, or (3) a research-related injury. Any other questions about the 
research project should be directed to: 
 
Travis Cluckey 
Biological Sciences (Building 21), room #223 
tgc6@nau.edu 
tel. 602-622-1432 
 
OR 
Tinna Traustadóttir, Ph.D. 
Peterson Hall (Building 22), room # 205 
tinna.traustadottir@nau.edu 
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Appenm 	  
Pre-Screen form used with recruitment script 
 
At this time, I will ask you a series of questions as a pre-
screening to determine your eligibility for a screening visit in 
our lab. This pre-screen includes questions about your health 
history and medication use. Based on this information you may 
not qualify for the study; however if you do qualify this 
information will be destroyed. Remember that answering these 
questions is completely voluntary, and you may refuse to 
answer any question asked.  
 
Are you over 18 years of age and do you want to continue with the pre-screen, allowing me to ask 
you health-related questions to determine your eligibility? Your name will be attached to this 
form only if you qualify, and will be removed promptly upon scheduling your screening visit 
 
o Yes, subject verbally consented to pre-screening and is over 18 years of age 
 
Name of study personnel __________________            Signature _______________________________ 
 
Date of verbal consent ________________________ ID _______________________________ 
 
o No, subject does not wish to continue  
 
 
------------------------------------------------------------------------------------------------------------------- 
 
Name ___________________________________ Date scheduled for Screening _________________ 
What is your weight kg lbs  What is your age?     
What is your height cm ____’ ______” 
     BMI (calculate on own)     
     
      
Yes No 
Have you ever been told by a medical provider that you have 
problems with:           
your heart, including heart attacks or coronary disease?               
high blood pressure?               
any type of cancer?               
diabetes?               
Do you smoke?                 
Have you meditated for more than 30 minutes a week in the past 3 months?       
Do you take a multi-vitamin or antioxidant              
 
How often and how much in the past month?         
  Have you used creatine supplementation in the past month?           
Are you currently on either estrogen or testosterone therapies?            
 
How often and how much in the past month?         
  Are you pregnant or planning to become pregnant?       
Do you exercise regularly?       
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Physical	Examination	Record		 Telomerase	Activity	study	 	
	Subject	ID:	______________________	 	 Date:	______________________	 		 		Age:	______________________	 	 	 D.O.B.	______________________			
	
Vital	Statistics		
	 	Height:	____________	meters	 	 Weight:	____________	Kilograms	 Waist:	____________	cm				
	
Vital	Signs		 		 		 	 	 	 	 Blood	Pressure:	_______/_______	mm	Hg	(systolic/diastolic)		 	 	 Pulse:	____________	
Resting	EKG			 	 Normal:	____________	 	 Abnormal:	____________		
Health	History	completed?	 Yes/No	
	
Are	there	any	Contraindications	to	maximal	exercise	test?	 	Yes/No						
VO2	Max	Results		
	Date	of	test:	______________________		Tester	initials:	______________________			 Protocol:	______________________	watts		Test	duration:	______________________	minutes		VO2	Max:	______________________	mL/kg/min		HR	max:	______________________	bpm		WL	max:	______________________	watts		RER	max:	______________________		
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Acute Exercise Testing Data 
 
Subject ID: ____________________  VO2max: _______________ 
 
Max HR: _______      
 
 
Protocol – HIIP @ 1 min 90%, 2 min 60% VO2max 
 
 
Date administered: ___________  Conducted by (initials): _______________    
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Administrative Comments:  
__________________________________________________________________________
__________________________________________________________________________ 
__________________________________________________________________________ 
 
 
Subject Comments:  
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
 
Blood Draw Time % Viable  
Pre 
 
  
+ 30  
 
  
+ 60 
 
  
 
+90   
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